2,16,19-Kauranetriol 2-O-beta-D-Allopyranosid

Catalog No. :
ACBCFG612
CAS No. :
195723-38-7
Molecular Formula :
C26H44O8
Molecular Weight :
484.63

IUPAC Name:(2R,3R,4R,5S,6R)-2-(((2S,4R,4aS,6aS,8R,9R,11aR,11bS)-8-hydroxy-4-(hydroxymethyl)-4,8,11b-trimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalen-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

2,16,19-Kauranetriol 2-O-beta-D-Allopyranosid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$410.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,16,19-Kauranetriol 2-O-beta-D-Allopyranosid
IUPAC Name(2R,3R,4R,5S,6R)-2-(((2S,4R,4aS,6aS,8R,9R,11aR,11bS)-8-hydroxy-4-(hydroxymethyl)-4,8,11b-trimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalen-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
MDL No.MFCD20260830
Molecular FormulaC26H44O8
Molecular Weight484.63
SMILESC[C@]12[C@]3([C@]4(C[C@@]([H])(CC3)[C@](O)(C4)C)CC[C@@]1([C@@](C[C@H](C2)O[C@@]5(O[C@H](CO)[C@H]([C@H]([C@H]5O)O)O)[H])(CO)C)[H])[H]
InChI KeyQCOICVPTIKZOPU-YCROVFPPSA-N
Synonym2,16,19-Kauranetriol 2-O-beta-D-allopyraside;2,16,19-Kauranetriol 2-O-beta-D-allopyranoside;2,16,19-Kauranetriol 2-O-β-D-allopyranoside;β-D-Allopyranoside, (2β,4α)-16,18-dihydroxykauran-2-yl (9CI);2,16,19-Kauranetriol2-O-β-D-allopyranoside;19-Kauranetriol 2-O-β-D-allopyranoside
CAS No.195723-38-7

Synthetic Route by SureRoute

1. ACBCFG612 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBCFG612 route product structure diagram
    ACBCFG612195723-38-7
Inquiry

2. ACBCFG612 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBCFG612 route product structure diagram
    ACBCFG612195723-38-7
Inquiry

Comments (0)